Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
Next >
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Tickers
ADVM
AFIB
AGTC
AKYA
Tags
ORPH
IBB
CMMB
From
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Tickers
ABEO
ACER
AFIB
AGTC
Tags
IBB
CMMB
MDWD
From
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Tickers
ADTX
AFIB
AGTC
ARAV
Tags
GLTO
AGTC
ELDN
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Tickers
ANIP
AVDL
BHC
CALT
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
More than a quarter of Nasdaq-100 stocks are in bear markets — Wall Street sees a buying opportunity
September 29, 2021
Tickers
AAPL
AMGN
AMZN
ATVI
Tags
ILMN
INTC
VRTX
From
MarketWatch
Only 47 stocks in the S&P 500 have fallen over the past year — Wall Street predicts they will climb up to 54% in 12 months
September 28, 2021
Tickers
AKAM
AMGN
APD
ATO
Tags
MRK
DLTR
CTXS
From
MarketWatch
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
Tickers
AFIB
ALT
AMZN
APYX
Tags
BIIB
EGRX
PFE
From
Benzinga
Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate
September 27, 2021
Tickers
INCY
SNDX
Tags
Market News
Benzinga
Trading Ideas
From
Benzinga
Expert Ratings For Incyte
September 23, 2021
Tickers
INCY
Tags
INCY
Analyst Ratings
Market News
From
Benzinga
Incyte, Knight Therapeutics Ink Distribution Pact For Two Cancer Drugs In Latin America
September 23, 2021
Tickers
INCY
Tags
Benzinga
Diffuse Large B/Cell Lymphoma
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
Tickers
AMGN
ANNX
AOSL
ARGX
Tags
AOSL
EAR
AVDL
From
Benzinga
BriaCell's Survival Story Could Mean a Better Chance of Survival for Women Suffering from Breast Cancer
September 23, 2021
Tickers
BCTX
INCY
Tags
Markets
General
News
From
Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Tickers
ABCL
ABSI
AFIB
ALZN
Tags
PDSB
AMAM
PLRX
From
Benzinga
10 Biggest Price Target Changes For Thursday
September 23, 2021
Tickers
FDX
INCY
KBH
LEN
Tags
FDX
Benzinga
OHI
From
Benzinga
Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD
September 22, 2021
Tickers
INCY
Tags
General
Movers
Briefs
From
Benzinga
Facebook, Incyte Fall Despite the Nasdaq's Strong Wednesday Start
September 22, 2021
Tickers
FB
INCY
Tags
INCY
Market News
FB
From
Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
Tickers
ABEO
ABSI
AFIB
AMAM
Tags
KROS
OYST
AFIB
From
Benzinga
Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
September 22, 2021
Tickers
INCY
Tags
Market News
FDA
Benzinga
From
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Tickers
ABSI
ADTX
AERI
AFIB
Tags
GLPG
HCWB
TYRA
From
Benzinga
Incyte's Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada
September 20, 2021
Tickers
INCY
Tags
FDA
Benzinga
Market News
From
Benzinga
Is AbbVie a Bad News Buy?
September 19, 2021
Tickers
ABBV
INCY
LLY
PFE
Tags
Market News
INCY
LLY
From
Motley Fool
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
Tickers
AGTC
APRE
BMY
BNTX
Tags
SRPT
Small Cap
Biotech
From
Benzinga
Price Over Earnings Overview: Incyte
September 14, 2021
Tickers
INCY
Tags
Intraday Update
Markets
Market News
From
Benzinga
FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To Know
September 02, 2021
Tickers
ABBV
BMY
INCY
LLY
Tags
PFE
Benzinga
FDA
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August 31, 2021
Tickers
ABBV
ASND
BGNE
BIIB
Tags
Previews
Small Cap
Biotech
From
Benzinga
If you’ve got the stock market jitters, here are 20 companies in two defensive sectors
August 30, 2021
Tickers
ABC
AES
ANTM
BAX
Tags
VRTX
CVS
CNC
From
MarketWatch
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Tickers
AGEN
ALKS
ALZN
BLFS
Tags
MXCT
IMGO
TBPH
From
Benzinga
Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval
August 27, 2021
Tickers
INCY
MOR
Tags
General
MOR
INCY
From
Benzinga
These 20 ‘left behind’ stocks among the S&P 500 are expected to rise up to 59% over 12 months
August 26, 2021
Tickers
AAPL
AMZN
ATVI
BAX
Tags
LW
FIS
NEM
From
MarketWatch
BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial
August 19, 2021
Tickers
BCTX
INCY
Tags
Contracts
Biotech
Health Care
From
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.